Shanton, Reaches

Shanton Reaches Full Enrollment in Phase 2b Refractory/ Tophaceous Gout Study with SAP-001

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Shanton Pharma New Jersey

View original content:https://www.prnewswire.co.uk/news-releases/shanton-reaches-full-enrollment-in-phase-2b-refractorytophaceous-gout-study-with-sap-001-302213949.html

en | boerse | 67961931 |